| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 07/19/2000 | EP1019396A1 Novel cycloalkyl substituted imidazoles |
| 07/19/2000 | EP1019387A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 07/19/2000 | EP1019376A1 Pyridone derivatives, their preparation and their use as synthesis intermediates |
| 07/19/2000 | EP1019373A1 Novel human nk 3? receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them |
| 07/19/2000 | EP1019372A1 Novel fused pyrrolecarboxamides; a new class of gaba brain receptor ligands |
| 07/19/2000 | EP1019053A1 Amorphous paroxetine composition |
| 07/19/2000 | EP1018879A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses |
| 07/19/2000 | EP0821682B1 Benzimidazole compounds and their use as modulators of the gaba-a receptor complex |
| 07/19/2000 | EP0667861B1 2-trifluoromethyl benzimidazole derivatives, their preparation and their use as pesticides |
| 07/19/2000 | EP0664291B1 Pyrimidine compound |
| 07/19/2000 | EP0482208B1 Pyridazinone derivative |
| 07/19/2000 | CN1260795A Quaternary ammonium compounds as tachykinin antagenists |
| 07/19/2000 | CN1260781A Indole derivatives having combined 5HT1A, 5HT1B and 5HT1D receptor antagoinist activity |
| 07/19/2000 | CN1054603C Tri-substituted phenyl derivatives and medicinal composition containing same |
| 07/18/2000 | US6090927 Cyanobutanone and succinonitrile substituted with ap-chlorophenylsulfonyl- and a 4-(trifluoromethyl)-2,6-dichlorophenylazo group |
| 07/18/2000 | US6090839 Antidiabetic agents |
| 07/18/2000 | US6090826 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity |
| 07/18/2000 | US6090817 Respiratory system disorders; phosphodiesterse inhibitor |
| 07/18/2000 | US6090815 Pyrimidinyloxyalkanoic amide derivatives and fungicides for agricultural and horticultural use |
| 07/18/2000 | US6090812 Therapy for psychological, central nervous system disorders |
| 07/18/2000 | US6090810 Side effect reduction |
| 07/18/2000 | US6090753 Pyridazin-3-one derivatives, their use, and intermediates for their production |
| 07/18/2000 | CA2117610C Indole derivatives as steroid 5 alpha-reductase inhibitors |
| 07/18/2000 | CA2017376C Diarylstyrylquinoline diacids |
| 07/18/2000 | CA2008616C Aryl- or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds useful in treating interleukin-1 mediated conditions |
| 07/13/2000 | WO2000040574A1 1,4-diazacycloheptane compounds, process for their preparation, and their use as medicaments |
| 07/13/2000 | WO2000040562A1 2-oxoquinoline compounds and medicinal uses thereof |
| 07/13/2000 | WO2000040561A1 Quinolinecarboxamides as antiviral agents |
| 07/13/2000 | WO2000040558A1 Aspartic protease inhibitors |
| 07/13/2000 | WO2000040554A1 Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression |
| 07/13/2000 | WO2000040539A1 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases |
| 07/13/2000 | WO2000021927A3 Pyrrole-2,5-diones as gsk-3 inhibitors |
| 07/13/2000 | WO2000006597A9 Endogenous constitutively activated g protein-coupled orphan receptors |
| 07/13/2000 | DE19900576A1 New substituted allyl-, glycidyl- or hydroxypropyl-benzene derivatives, used as intermediates for drugs, especially central nervous system drugs, particularly the antidepressants paroxetine and femoxetine |
| 07/13/2000 | CA2358879A1 2-oxoquinoline compounds and pharmaceutical uses thereof |
| 07/13/2000 | CA2356053A1 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases |
| 07/13/2000 | CA2355342A1 Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression |
| 07/13/2000 | CA2353636A1 Quinolinecarboxamides as antiviral agents |
| 07/12/2000 | EP1018008A2 Method of identification of leads or active compounds |
| 07/12/2000 | EP1017692A1 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein |
| 07/12/2000 | EP1017691A1 Bisethers of 1-oxa, aza and thianaphthalen-2-ones as phospholamban inhibitors |
| 07/12/2000 | EP1017687A1 Process of making 3-aryloxy, 4-aryl furan-2-ones useful as inhibitors of cox-2 |
| 07/12/2000 | EP1017680A1 Tricyclic compounds, preparation method and said method intermediates, application as medicines and pharmaceutical compositions containing same |
| 07/12/2000 | EP1017664A1 C3a receptor ligands |
| 07/12/2000 | EP1017395A1 Method for treating premenstrual or late luteal phase syndrome |
| 07/12/2000 | EP1017393A1 Pyrazinone thrombin inhibitors |
| 07/12/2000 | EP1017385A1 USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MAKING MEDICINES ACTING ON TGF-beta 1 |
| 07/12/2000 | EP0892917A4 Infrared imager using room temperature capacitance sensor |
| 07/12/2000 | EP0877734B1 Quinoline and quinazoline compounds useful in therapy |
| 07/12/2000 | EP0745073B1 5-substituted derivatives of mycophenolic acid |
| 07/12/2000 | EP0720600B1 3-(3,4-dioxyphenyl)-pyrrolidines as type iv phosphodiesterase inhibitors for the treatment of inflammatory diseases |
| 07/12/2000 | CN1259943A Substituted aryluracils |
| 07/12/2000 | CN1259936A Method for producing nitroguanidine derivatives |
| 07/12/2000 | CN1259935A Substituted naphthopyrans |
| 07/11/2000 | US6087501 Hydrolysis of imines to form amides |
| 07/11/2000 | US6087482 Heteroatomic oligonucleoside linkages |
| 07/11/2000 | US6087392 (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides |
| 07/11/2000 | US6087389 Endothelin receptor antagonists |
| 07/11/2000 | US6087360 Method of treating heart failure with endothelin antagonists |
| 07/11/2000 | US6087357 Piperazine derivatives as tachykinin antagonists |
| 07/11/2000 | US6087186 Synthetic library of random oligomers, each member comprising an oligomer linked to a microchip encoded with information identifying structure of oligomer; for drug screening |
| 07/11/2000 | US6086865 O-chloracetylcarbamoylfumagillol and interferon; synergistic angiogenesis inhibitory effect |
| 07/11/2000 | CA2208569C Novel processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof |
| 07/11/2000 | CA2012851C Purinyl and pyrimidinyl tetrahydrofurans |
| 07/06/2000 | WO2000039245A1 Photochromatic compounds, process for their preparation and their use in polymeric materials |
| 07/06/2000 | WO2000039125A1 Piperidines as ccr5 modulators |
| 07/06/2000 | WO2000039122A1 Process for the preparation of an acetate salt of paroxetine or paroxetine analogues |
| 07/06/2000 | WO2000039121A1 Process for the preparation of an acetate salt of paroxetine or paroxetine analogues |
| 07/06/2000 | WO2000039120A2 Compounds and methods for modulation of estrogen receptors |
| 07/06/2000 | WO2000039119A1 Novel inhibitors of farnesyl-protein transferase |
| 07/06/2000 | WO2000039118A1 Aromatic amides |
| 07/06/2000 | WO2000039117A1 HETEROROAROMATIC AMIDES AS INHIBITOR OF FACTOR Xa |
| 07/06/2000 | WO2000039116A1 Aminopyrazole derivatives |
| 07/06/2000 | WO2000039115A1 Protease inhibitors |
| 07/06/2000 | WO2000039114A2 Substituted oximes and hydrazones as neurokinin antagonists |
| 07/06/2000 | WO2000039110A1 Homopiperazine derivatives as selective emopamil inhibitors |
| 07/06/2000 | WO2000039105A1 1,4-diazacycloheptane derivatives useful in the treatment of neurological disorders |
| 07/06/2000 | WO2000039104A1 Phenazine compounds, methods and pharmaceutical compositions for inhibiting parp |
| 07/06/2000 | WO2000039099A1 Benzimidazole derivatives |
| 07/06/2000 | WO2000039097A1 Imidazole compounds and medicinal use thereof |
| 07/06/2000 | WO2000039094A1 Substituted pyridine herbicides |
| 07/06/2000 | WO2000039092A1 HETEROCYCLIC AMIDES AS INHIBITORS OF FACTOR Xa |
| 07/06/2000 | WO2000039090A1 Process for the preparation of paroxetine acetate and analogues thereof |
| 07/06/2000 | WO2000039089A1 3-azabicyclo[3.1.0.] hexane derivatives as opiate receptors ligands |
| 07/06/2000 | WO2000039088A1 Glucagon antagonists/inverse agonists |
| 07/06/2000 | WO2000039081A2 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 07/06/2000 | WO2000038786A2 Use of cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | WO2000038730A2 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia |
| 07/06/2000 | WO2000038719A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia |
| 07/06/2000 | WO2000038718A2 Use of matrix metalloproteinase inhibitor together with an antineoplastic agents, optionally also together with radiation, in the treatment of neoplasia |
| 07/06/2000 | WO2000038717A2 Use of a matrix metalloproteinase inhibitor and radiation as a combined treatment of neoplasia |
| 07/06/2000 | WO2000038715A2 Use of an integrin antagonist and radiation in the treatment of neoplasia |
| 07/06/2000 | WO2000038687A1 Protease inhibitors |
| 07/06/2000 | WO2000038680A1 Azabicycloalkanes as ccr5 modulators |
| 07/06/2000 | WO2000038677A1 Indole and indolizidine derivatives for the treatment of migraine |
| 07/06/2000 | WO2000038665A2 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2361149A1 Aromatic amides |
| 07/06/2000 | CA2358095A1 Heteroroaromatic amides as inhibitor of factor xa |
| 07/06/2000 | CA2356986A1 Compounds and methods for modulation of estrogen receptors |
| 07/06/2000 | CA2356929A1 Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combonation therapy in the treatment of neoplasia |